Smith & Nephew plc vs Vistra Corp — how do they compare? Smith & Nephew plc trades at $30.05 (market cap $12.54B), while Vistra Corp trades at $145.8 (market cap $48.64B). The key difference: Vistra Corp is far larger — about 3.9× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.65%). Which is the better fit depends on your goals.
| SNN | VST | |
|---|---|---|
Market Cap | $12.54B | $48.64B |
Sector | Health | Technology |
52-Week High | $38.70 | $217.92 |
52-Week Low | $28.73 | $134.71 |
Enterprise Value | $15.57B | $70.58B |
Dividend Yield | 2.65% | 0.63% |
Trailing returns across standard periods
Latest headlines on both assets
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →